111 related articles for article (PubMed ID: 6102405)
1. The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
Allen L; Meck R; Yunis A
Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):175-82. PubMed ID: 6102405
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of gamma-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells by L-(alpha S, 5S)-alpha-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
Reed DJ; Ellis WW; Meck RA
Biochem Biophys Res Commun; 1980 Jun; 94(4):1273-7. PubMed ID: 6104962
[No Abstract] [Full Text] [Related]
3. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Meck RA; Clubb KJ; Allen LM; Yunis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
[No Abstract] [Full Text] [Related]
5. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
[TBL] [Abstract][Full Text] [Related]
6. Interaction of AT-125, (alpha S,5S)-amino-3-chloro-4,5-dihydroisoxazoleacetic acid, with bovine kidney gamma-glutamyl transpeptidase.
Allen LM; Corrigan MV; Meinking T
Chem Biol Interact; 1981 Jan; 33(2-3):361-5. PubMed ID: 6109574
[No Abstract] [Full Text] [Related]
7. Interaction of the antitumor drug, L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125) with renal brush border membranes. Specific labeling of gamma-glutamyl transpeptidase.
Kozak EM; Tate SS
FEBS Lett; 1980 Dec; 122(2):175-8. PubMed ID: 6110565
[No Abstract] [Full Text] [Related]
8. Acivicin. An antitumor antibiotic.
Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
[TBL] [Abstract][Full Text] [Related]
9. Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; Bhuyan BK; Blowers CL; Kuentzel SL
Adv Enzyme Regul; 1978; 17():375-98. PubMed ID: 757314
[No Abstract] [Full Text] [Related]
10. Effect of L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid on urinary excretion of methylmercury in the mouse.
Mulder KM; Kostyniak PJ
J Pharmacol Exp Ther; 1985 Jul; 234(1):156-60. PubMed ID: 4009498
[TBL] [Abstract][Full Text] [Related]
11. The effect of the glutamine analog, AT-125, on the cell cycle of MCF-7 and BT-20 human breast carcinoma cells using DNA flow cytometry.
Thornthwaite JT; Allen LM
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):393-6. PubMed ID: 6106266
[TBL] [Abstract][Full Text] [Related]
12. Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
Drieman JC; Thijssen HH; Struyker-Boudier HA
J Pharmacol Exp Ther; 1990 Mar; 252(3):1255-60. PubMed ID: 1969473
[TBL] [Abstract][Full Text] [Related]
13. Affinity labeling of gamma-glutamyl transpeptidase by glutamine antagonists. Effects of the gamma-glutamyl transferase and proteinase activities.
Gardell SJ; Tate SS
FEBS Lett; 1980 Dec; 122(2):171-4. PubMed ID: 6110564
[No Abstract] [Full Text] [Related]
14. Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Tso JY; Bower SG; Zalkin H
J Biol Chem; 1980 Jul; 255(14):6734-8. PubMed ID: 6993476
[TBL] [Abstract][Full Text] [Related]
15. Absence of a role of gamma-glutamyl transpeptidase in the transport of amino acids by rat renal brushborder membrane vesicles.
Hsu BY; Foreman JW; Corcoran SM; Ginkinger K; Segal S
J Membr Biol; 1984; 80(2):167-73. PubMed ID: 6148423
[TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Holcenberg JS
Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
[TBL] [Abstract][Full Text] [Related]
17. The binding mechanism of glutathione and the anti-tumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125;NSC-163501) to gamma-glutamyltransferase.
Schasteen CS; Curthoys NP; Reed DJ
Biochem Biophys Res Commun; 1983 Apr; 112(2):564-70. PubMed ID: 6133518
[TBL] [Abstract][Full Text] [Related]
18. Effects of AT-125 on the nephrotoxicity of hexachloro-1,3-butadiene in rats.
Davis ME
Toxicol Appl Pharmacol; 1988 Aug; 95(1):44-52. PubMed ID: 2901150
[TBL] [Abstract][Full Text] [Related]
19. Effects of bile acids and their glycine conjugates on gamma-glutamyl transpeptidase.
Gardell SJ; Tate SS
J Biol Chem; 1983 May; 258(10):6198-201. PubMed ID: 6133861
[TBL] [Abstract][Full Text] [Related]
20. A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo.
Martin DG; Hanka LJ; Neil GL
Cancer Chemother Rep; 1974; 58(6):935-7. PubMed ID: 4217217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
